Director Files Intent to Sell $3 Million in Atai Beckley Stock
ATAI has more than doubled off its 52-week low of $1.15 on elevated volume (2.5× avg).
Summary
Atai Beckley N.V. Director Cosmo Feilding-Mellen has filed a Form 144 indicating an intent to sell 750,000 shares of common stock, valued at approximately $3 million.
Key Events · Ownership and Investor Activity · ATAI
-
Director Files Intent to Sell
Cosmo Feilding-Mellen, a Director of Atai Beckley N.V., has filed a Form 144 to sell 750,000 shares of common stock.
-
Significant Value
The proposed sale has an approximate market value of $3,000,000.00.
-
Shares Acquired via RSU
The shares were acquired on December 24, 2025, through restricted stock units as equity compensation.
Analysis · ATAI · Life Sciences
This Form 144 filing signals a significant intent to sell by a company director. While the shares were acquired recently through restricted stock units, the proposed sale of $3 million worth of stock represents a notable disposition by an insider. Investors may view this as a potential lack of confidence or a move to diversify holdings, which could exert some downward pressure or create an overhang on the stock.
At the time of this filing, ATAI was trading at $3.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $1.15 to $6.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.